Stearoyl-CoA desaturase 1 (SCD1) suppresses ovarian cancer cell ferroptosis [107], while the inhibition of pharmaceutical SCD1 promotes ferroptosis in vitro and in vivo, and the combined treatment of SCD1 inhibitors and ferroptosis inducers significantly inhibits ovarian tumor growth [108]. The gene discussed is SCD; the disease is ovarian carcinoma.